|
|
|
global edition > new drugs
Recently Approved Drugs/Indications
- News found on the Internet relating to the approval of new drugs or of new indications for previously available drugs.
- Pages updated in the past seven days.
-
New Tylenol (Acetaminophen/Pamabrom), For Menstrual Pain And Bloating, Available In US
-
Menjugate Meningitis Vaccine Approved In UK and Ireland For Infants Older Than Two Months
-
FDA Approves Pepcid Complete (Calcium Carbonate, Magnesium Hydroxide) For Heartburn And Acid Indigestion
-
FDA Approves Glucophage XR (Metformin) Extended Release Formulation For Type 2 Diabetes
-
FDA Approves Novantrone (Mitoxantrone) For Worsening Forms Of Multiple Sclerosis
-
FDA Approves Depakote (Divalproex) Extended Release For Migraine Prevention
-
Flu Test Now Available For Widespread Use In The U.S.
-
UK Approves Actiq (Oral Transmucosal Fentanyl Citrate) For Management Of Breakthrough Pain
-
FDA Approves Cholesterol Drug, Lescol XL (Fluvastatin), Extended Release
-
FDA Approves Lunelle Monthly Contraceptive Injection (Medroxyprogesterone Acetate/Estradiol Cypionate)
-
FDA Approves New Indication For Altace (Ramipril), To Reduce Risk of Stroke, Heart Attack
-
Lodine (Etodolac) Lot Subject Of Urgent Voluntary Recall
-
Asthma Drug, Pulmicort Respules (Budesonide), Available In US
-
Norditropin Cartridges, Premixed Growth Hormone, Available In The US
-
FDA Approves Flovent Diskus (Fluticasone Propionate) For Asthmatics Four Years And Older
-
European Union Approves Anti-Epileptic Keppra (Levetiracetam)
-
FDA Grants Marketing Approval For Ovidrel (Choriogonadotropin Alfa) For Infertility Treatment
-
FDA Approves Mifeprex (Mifepristone) To End Early Pregnancies
-
Zadaxin (Thymalfasin) Approved For Hepatitis C In Mexico, Peru, Sri Lanka
-
FDA Approves Trisenox (Arsenic Trioxide) For Acute Promyelocytic Leukemia Unresponsive To Standard Therapy
-
Japan Approves Antiviral Zevix (Lamivudine) For Hepatitis B
-
Modafinil Available In Switzerland for Treatment of Narcolepsy
-
FDA Grants Orphan Drug Status To Thymoglobulin (Anti-Thymocyte Globulin) For Myelodysplastic Syndrome
-
FDA Approves QVAR (Beclomethasone Dipropionate HFA) Inhalation Aerosol For The Treatment Of Asthma
-
FDA Grants Accelerated Approval To Antiretroviral Kaletra (Lopinavir/Ritonavir) For Adults And Children
-
FDA Approves Atrisorb Tissue Regeneration Barrier With Doxycycline
-
Canada Approves Once-A-Day Oral Diabetic Drug, Actos (Pioglitazone)
-
Combination Lithotripsy/Actigall (Ursodio) Therapy Approved In US For Gallstones
-
Norplant Users Urged to Use Back-up Contraception
-
Europe Approves Expanded Indications For Cystistat (Hyaluronic Acid)
-
FDA Approves New Formulation Of Renova (Tretinoin Cream) For Reduction Of Fine Facial Wrinkles
-
FDA Approves Atacand HCT (Candesartan Cilexetil HCl) For Hypertension
-
FDA Approves Arimidex (Anastrozole) For Hormone Receptive Advanced Breast Cancer
-
Sweden Approves Antipsychotic Zeldox (Ziprasidone), Intramuscular Formulation
-
FDA Approves Cipro (Ciprofloxacin) For Post-Exposure Inhalational Anthrax
-
Canada Approves Estrogen-Suppressant Aromasin (Exemestane) For Advanced Breast Cancer
-
FDA Approves Vaccine Tripedia For Fifth Consecutive Dose For Pediatric Immunizations
-
FDA Approves Dual-Action Advair Diskus (Fluticasone Propionate And Salmeterol) For Asthma
-
FDA Creates Guide For Lotronex (Alosetron), Labeling Revised To Help Manage Risks
-
FDA Grants Orphan Drug Status To Veldona (Interferon-Alpha) For Oral Warts In HIV-Positive Patients
-
FDA Approves Azulfidine EN-Tabs (Sulfasalazine) To Treat Rheumatoid Arthritis In Children
-
FDA Approves Unithroid (Levothyroxine), Thyroid Hormone Replacement, For Use In Adults And Children
-
Actonel (Risedronate), For Osteoporosis, Approved In Canada
-
FDA approves Quixin (levofloxacin) For Bacterial Conjuctivitis
-
Docs Advised To Suspend Use Of Newer Norplant (levonorgestrel implants) Kits
-
FDA Approves Vivelle (estradiol transdermal system) For Postmenopausal Osteoporosis
-
Luveris (Lutropin Alfa) Recommended For Approval In Europe For Female Infertility Treatment
-
The U.K. Approves Copaxone (Glatiramer Acetate) For Relapsing-remitting Multiple Sclerosis
-
Europe Approves Helixate Nexgen Recombinant Product For Hemophilia A
-
FDA Grants Orphan Drug Status To Wobe-Mugos For Multiple Myeloma
-
FDA Approves CellCept (Mycophenolate Mofetil) To Help Prevent Rejection Of Liver Transplants
-
FDA Approves Pulmicort Nebulized Corticosteroid (Budesonide) For Asthmatic Children
-
Argentina Grants Extended Approval For Zadaxin (Thymalfasin) For Hepatitis B And C
-
FDA Approves Fragmin (Dalteparin) For Prevention Of Deep Vein Thrombosis Post-Op
-
FDA Approves Glucovance (Glyburide And Metformin) For Type 2 Diabetes
-
Once-Daily Concerta (Methylphenidate) For Attention Deficit Hyperactivity Disorder Approved In US
-
FDA Approves Vaniqa (Eflornithine Hydrochloride) 13.9% For Women With Unwanted Facial Hair
-
Europe Approves Myocet (Liposome Encapsulated Doxorubicin Citrate) For Breast Cancer
-
FDA Panel Recommends Approval Of Cipro For Treating Anthrax Exposure
-
Europe Approves Visudyne (Verteporfin) For Wet Age-Related Macular Degeneration
-
Three Lots of Imovax Rabies Pre-Exposure Vaccine Voluntarily Recalled
-
FDA Approves Non-Prescription Cold Sore Topical Treatment Docosonal 10%
-
FDA Approves New Baycol (Cerivastatin) Dosage And Additional Indication For Hypercholesterolemia
-
FDA Approves Colazal (Balsalazide Disodium) For Ulcerative Colitis
-
FDA Committee Recommends Approval For Zeldox (Ziprasidone) For Schizophrenia
-
UK Approves Neis-Vac-C Meningococcal Vaccine For Individuals One Year And Older
-
Europe Recommends Approval Of Trizivir (Lamivudine/Abacavir Sulphate/Zidovudine) For HIV
-
Arsenic Trioxide Receives FDA Orphan Drug Designation For Myelodysplastic Syndromes
-
Tylenol (Acetaminophen) To Be Available In Japan In Early Fall
-
FDA Approves Once-Daily Innohep (Tinzaparin) For Deep Vein Thrombosis
-
Canada Approves Sale Of Valtaxin (Valrubicin) For Bladder Cancer
-
Antidepressant Effexor XR (Venlafaxine) Given FDA Approval For Generalized Anxiety Disorder
-
Vioxx (Rofecoxib) Available In Canada In Oral Suspension
-
FDA Approves Malarone (Atovaquone/Proguanil Hydrochloride) To Prevent And Treat Malaria
-
Australia Approves WinRho SDF For Blood-Type Incompatibility Between Mother And Unborn Child
-
Europe Approves Nexium (Esomeprazole) For Gastroesophageal Reflux Disease
-
FDA Approves Renagel Tablets (Sevelamer Hydrochloride) For Hemodialysis Patients
-
FDA Recommends Approval of Remicade (Infliximab) With Methotrexate For Rheumatoid Arthritis Joint Damage
-
FDA Approves Shorter Regimen For Cancer Drug Taxol (Paclitaxel)
-
OxyContin (oxycodone HCl controlled-release) Tablets Now Available In 160 mg Formulation
-
FDA Approves Fluoxetine To Treat Premenstrual Dysphoric Disorder
-
FDA Approves Ambisome (Amphotericin) For Cryptococcal Meningitis In AIDS Patients
-
FDA Approves New Use For Breast Cancer Drug Nolvadex (Tamoxifen)
-
European Panel Gives Positive Opinion On Approval Of Agenerase (Amprenavir) For HIV
-
Argatroban Approved For Prevention Or Treatment Of Thrombosis In Heparin-Induced Thrombocytopenia
-
European Drug Advisory Committee Recommends CAELYX For Advanced Ovarian Cancer
-
Nutropin Depot (Somatropin (rDNA)) Growth Hormone Available In The US
-
Next Generation Formulation Offers Safety, Convenience For Hemophilia A
-
FDA Approved Kogenate FS Antihemophilic Factor (Recombinant) For Hemophilia A
-
European Union Approves Remicade (Infliximab) for Rheumatoid Arthritis
-
FDA Committee Recommends Zelmac (Tegaserod) For Women With Irritable Bowel Syndrome
-
Non-Nicotine Smoking Cessation Zyban (Bupropion Hydrochloride SR) Launched In UK
-
FDA Approves Cool.click Needle Free Device For Saizen (Somatropin) Growth Hormone
-
Varivax Chicken Pox Vaccine Available In Canada
-
FDA Approves Genotropin (Somatropin [Rdna Origin] For Injection) For Prader-Willi Syndrome
-
Exelon (Rivastigmine Tartrate) Now Available In US For Alzheimer's Disease
-
FDA Approves Apligraf For Treatment Of Diabetic Foot Ulcers
-
FDA Approves Liquid Norditropin (Somatropin [rDNA Origin] Injection) Growth Hormone
-
UK Approves Ditropan XL (Oxybutynin) For Urinary Incontinence
-
FDA Approves Optivar (Azelastine) Ophthalmic Solution For Allergic Conjunctivitis In Patients Three Years And Older
-
FDA Approves One-Dose Gynazole-1 (Butoconazole Nitrate) For Vaginal Yeast Infections
-
Chlorofluorocarbon-Free Beclomethasone Inhaler Available In Japan For Asthmatics
-
FDA Approves Novolog (Insulin Aspart) For Diabetes Mellitus
-
Enbrel (Etanercept) Approved for First-Line Treatment of Moderately to Severely Active Rheumatoid Arthritis
-
Arimidex (Anastrozole) Approved in Canada For First-Line Treatment Of Postmenopausal Breast Cancer
-
Allegra (Fexofenadine) Available In US For Children With Seasonal Allergic Rhinitis Or Chronic Idiopathic Urticaria
-
FDA Approves TNKase (Tenecteplase) Single-Bolus Thrombolytic For Heart Attacks
-
FDA Approves Gonal-F (Follitropin Alfa) for Male and Female Infertility
-
Canada Approves QVAR Inhaler, Effective at Half the Dose of Most Other Inhalers
-
Health Canada Approves Visudyne (Verteporfin) for Age-Related Macular Degeneration
-
FDA Approves Cold Sore Treatment Docosanol 10% Cream, Over-The-Counter
-
Tobi (Tobramycin) Receives Patent In Europe For Lung Infections In Cystic Fibrosis Patients
-
FDA Approves Olux (Clobetasol Propionate) Foam For Scalp Dermatoses
-
FDA Approves Welchol (Colesevelam) Lipid-Lowering Agent
-
European Union Approves Pegintron (Peginterferon Alfa-2b) For Hepatitis C
-
Mylotarg (Gemtuzumab Ozogamicin) Approved By FDA for Leukemia
-
Canada Approves Pantoloc (Pantoprazole) for Maintenance Therapy of Ulcers and Heartburn
-
Protonix (Pantoprazole) Available in US for Short-Term Treatment Of Erosive Esophagitis
-
Rebetol (Ribavirin) Capsules for Hepatitis C Available in France
-
FDA Approves Extended Release Methylin (Methylphenidate) for Attention Deficit Hyperactivity Disorder
-
FDA Approves Slower Dose, Titration Schedule for Anti-Epileptic Drug Topamax (Topiramate)
-
Blood Test to Detect Several Types of Cancer Available in US
-
FDA Approves Reintroduction of Inversine (Mecamylamine) for Tourette's Syndrome
-
Canada Approves New Indications For Interstitial Cystitis Drug, Cystistat (Hyaluronic Acid)
-
Cafcit (Caffeine Citrate) Approved in U.S. for Pre-Term Infants with Respiratory Problems
-
Rebetol (Ribavirin) Available In Spain for Combination Hepatitis C Therapy
-
FDA Grants Orphan Drug Designation to Recombinant Human Antithrombin III for Anticoagulation
-
Evista (Raloxifene) Approved in Europe for Postmenopausal Osteoporosis
-
ASCO: FDA Assigns Orphan Drug Designation to Arsenic TriOxide For Multiple Myeloma
-
FDA approves Tri-Nasal (triamcinolone acetonide) for allergic rhinitis
-
FDA approves new indications for Humalog (insulin lispro) in children and the elderly
-
New Desenex Max Cream Takes Fewer Applications To Cure Athlete's Foot
-
Canada Approves Marinol (Delta-9-Tetrahydrocannabinol) For AIDS-Related Anorexia
-
Canada Approves Paxene (Paclitaxel) For AIDS-Related Kaposi's Sarcoma
-
Advil (ibuprofen) Migraine Available In US
-
Once-Daily Biaxin XL (Clarithromycin) Available In US For Sinusitis And Chronic Bronchitis
-
FDA Grants Marketing Clearance For Alzheimer's Drug Exelon (Rivastigmine Tartrate)
-
FDA Approves Once-Daily Lantus (Insulin Glargine) For Diabetes
-
FDA Approves Camptosar (Irinotecan Hydrochloride) In Combo Therapy For Metastatic Colorectal Cancer
-
Canada Approves Aggrenox (Dipyridamole/ASA) For Prevention Of Recurrent Strokes
-
UK Approves CFC-Free Salamol (Albuterol) Inhaler For Asthma
-
FDA Approves Zyvox (Linezolid) For Gram-Positive Infections
-
Clear NicoDerm CQ Now Available In US
-
Canada Approves Taxol (Paclitaxel) Adjuvant Therapy For Early Breast Cancer
-
FDA Issues Urgent Warning On TriCitrasol Dialysis Catheter Anticoagulant
-
European Union Approves Humalog (Insulin Lispro) For Diabetic Children And Adolescents
-
FDA Approves Actonel (Risedronate) For Osteoporosis
-
FDA Approves Clotrimazole Three-Day Cream 2% For Vaginal Yeast Infections
-
Canada Approves Taxol (Paclitaxel) For Adjuvant Treatment Of Breast Cancer
-
FDA Approves Activella (Estradiol/Norethindrone) For Prevention Of Postmenopausal Osteoporosis
-
Mobic (Meloxicam) Approved in US for Osteoarthritis
-
European Advisory Panel Backs Myocet (Liposome Encapsulated Doxorubicin Citrate Complex) For Breast Cancer
-
European Committee Recommends Approval Of Visudyne (Verteporfin) For Wet Age-Related Macular Degeneration
-
South Korea Approves Zadaxin (Thymosin Alpha 1) As An Influenza Vaccine Adjuvant
-
Once Daily Xatral (Alfuzosin) Launched In Europe For Benign Prostatic Hypertrophy
-
FDA Approves Visudyne For Age-related Macular Degeneration
-
FDA Grants Priority Review For Zelmac (Tegaserod) For Irritable Bowel Syndrome
-
FDA Committee Recommends Enbrel (etanercept) for Early Rheumatoid Arthritis
-
FDA Committee Recommends Uprima (Apomorphine) Sublingual Tablets For Erectile Dysfunction
-
FDA Approves Hectorol (Doxercalciferol) Injection For Secondary Hyperparathyroidism
-
Prosorba Column Launched in Europe for Rheumatoid Arthritis
-
Canada Approves Rituxan (Rituximab), New Class Of Drugs For Non-Hodgkin's Lymphoma
-
FDA Approves Avandia (Rosiglitazone) In Combo Therapy For Type 2 Diabetes
-
Arava (Leflunomide) Launched In Canada For Rheumatoid Arthritis
-
Canada Approves Avandia (Rosiglitazone Maleate) For Insulin Resistance
-
Schering Recalls Certain Asthma Aerosol Inhalers
-
FDA Approves Zonegran (Zonisamide) For Epilepsy
-
FDA Committee Recommends Approval Of New Antibiotic, Zyvox (Linezolid)
-
Minesse (Gestodene/Ethinyl Estradiol), Low-Dose Contraceptive, Approved In Europe
-
FDA Grants Orphan Drug Status To Zadaxin (thymalfasin) For Liver Cancer
-
Humalog Mix75/25 (Insulin Lispro Protamine Suspension/Insulin Lispro Injection) Now Available in US
-
Canada Approves Antifungal Agent AmBisome (Amphotericin B)
-
FDA Committee Recommends Approval Of Mylotarg (Gemtuzumab Ozogamicin) For AML
-
FDA Approves Zyprexa (Olanzapine) For Manic Episodes In Bipolar Disorder
-
Zadaxin (Thymalfasin) Approved In Thailand, Laos And Malta For Hepatitis B And C
-
FDA Committee Recommends Camptosar (Irinotecan) For Colorectal Cancer
-
ACC Issues Clinical Alert On Use Of Cardura (Doxazosin) For Hypertension
-
Ferriprox (Deferiprone), For Thalassemia, Launched In Europe
-
Japan Approves Novoseven Coagulation Factor VIIa (Recombinant) For Hemophilia
-
Drug Notification Issued For Pulmozyme (Dornase Alfa, Recombinant) Due To Packaging Defect
-
FDA Approves 1.25 Mg Cenestin (Synthetic Conjugated Estrogens) Tablets
-
Synercid (Quinupristin/Dalfopristin), Antibiotic For Severe Infections, Available In Canada
-
Antiseptic Sterile Products Recalled, Potential For Bacterial Contamination
-
Japan Approves Lipitor (Atorvastatin Calcium) A Lipid-Lowering Agent
-
Halofuginone Receives FDA Orphan Drug Status For Scleroderma
-
Israel Approves Busulfex (Busulfan) Chemotherapeutic Agent
-
FDA Approves Pacis BCG For Treatment Of Bladder Cancer
-
FDA Grants Orphan Drug Designation To Pentacea For Small Cell Lung Cancer
-
Prosorba Column Approved In Canada For Symptoms Of Rheumatoid Arthritis
-
FDA Approves Refacto Antihemophilic Factor Therapy For Hemophilia A
-
FDA Approves Extended-Release Biaxin (Clarithromycin) For Acute Sinusitis
-
FDA Approves Singulair (Montelukast Sodium) For Asthmatics As Young As Two Years
-
FDA Approves Viadur (Leuprolide) Implant For Advanced Prostate Cancer
-
FDA Approves Film-Coated Viracept (Nelfinavir Mesylate) For HIV
-
Reminyl (Galantamine) Approved In Sweden For Alzheimer's-Related Dementia
-
Prepulsid (Cisapride) Labelling Revised In Canada
-
Alocril (Nedocromil) Drops Available In US For Itchy Eyes Due To Allergies
-
FDA Approves Prescription AndroGel For Low Testosterone
-
FDA Approves New Allegra (Fexofenadine) Dosage For Allergic Rhinitis
-
FDA Approves Betapace AF (Sotalol) For Atrial Fibrillation And Atrial Flutter
-
Australia Approves Tobi (Tobramycin) For Cystic Fibrosis Patients With Pneumonia
-
Benadryl Allergy/Cold Fastmelt Tablets Now Available In The US
-
European Advisory Panel Recommends Approval Of Pegintron For Hepatitis C
-
Extra Strength Cardizem CD (Diltiazem HCl) Available In US For Hypertension And Angina
-
OraTest Oral Cancer Detection Product Launched In Greece
-
DG DISPATCH - AAEM: Expert Evaluates New Drugs
-
Feosol Elixir Iron Supplement Recalled
-
Diastat (Diazepam) Available In Canada As A Rectal Gel For Uncontrolled Seizures
-
FDA Approves Cafcit Injection For Apnea In Preterm Infants
-
Anti-Parkinson Drug, Requip (Ropinirole), Can Cause Patients To Fall Asleep Without Warning
-
FDA Approves Actimmune For Children With Osteopetrosis
-
Sustiva First Anti-HIV Drug Approved By FDA Based On Long Term Efficacy
-
Canada Approves Miacalcin NS Nasal Spray For Osteoporosis
-
Enbrel Approved In Europe For Rheumatoid And Juvenile Arthritis
-
Rhinocort Aqua Available In The US For Adults And Children With Allergic Rhinitis
-
Europe Approves Renagel Capsules For Hyperphosphatemia In Hemodialysis
-
FDA Approves Levaquin For Penicillin-Resistant S. Pneumoniae
-
FDA Approves Protonix Tablets For Erosive Esophagitis
-
FDA Panel Unanimously Recommends Approval For Novantrone For Multiple Sclerosis
-
Primsol Approved By FDA For Acute Otitis Media In Children
-
Prescribing Information Revised For GERD Treatment, Propulsid
-
Aromasin Now Available In US For Advanced Breast Cancer
-
Single-Use Genotropin, For Growth Hormone Deficiency, Available In US
-
Two-Dose Hepatitis B Vaccine, Recombivax HB, Approved For Adolescents
-
Immunosuppressant Rapamune Tablet Formulation Approved By FDA
-
New Type Of Quinolone Antibiotic, Tequin, Approved By FDA for RTIs
-
Anticonvulsant, Trileptal, Approved By FDA For Patients As Young As Four
-
FDA Approves HDL-Cholesterol Test For Patients With Diabetes And Heart Disease
-
FDA Tells Physicians: Remember Therapeutic Considerations Before Prescribing New Flu Drugs
-
Tequin, Antibiotic For Respiratory Infections, Approved By FDA
-
FDA Approves Oral Solution of Antidepressant Celexa
-
Maxamine, Adjunct Therapy For Leukemia, Granted Orphan Drug Status In US
-
Israel Approves Tobi, Antibiotic For Lung Infections
-
Japan Approves Relenza, Inhalation Treatment For Flu
-
FDA Approves Targretin Capsules For Cutaneous T-Cell Lymphoma
-
FDA Approves INOmax Treatment To Help Critically Ill Newborns Breathe
-
FDA Approves Nutropin Depot For Pediatric Growth Hormone Deficiency
-
FDA Approved Celebrex In Adjunct Therapy For Familial Adenomatous Polyposis
-
FDA Approves Taxotere For Non-Small Cell Lung Cancer
-
Europe Approves Synercid, For Vancomycin-Resistant Infections
-
Carnitor Approved In US For End Stage Renal Disease
-
Percocet Now Available In Three New Strengths
-
Tequin Approved By FDA, Available By Year End
-
Emergency Contraceptive, PREVEN, Available In Canada
-
Ciclopirox, Topical Treatment For Nail Fungus, Approved By FDA
-
Switzerland Approves Visudyne For Treatment Of Age-Related Macular Degeneration
-
FDA Committee Recommends Approval Of Celebrex For Familial Adenomatous Polyposis
-
Relenza, An Inhaled Anti-Flu Medication, Now Available Across Canada
-
FDA Advisory Panel Recommends Expanded Use Of Taxotere For Lung Cancer
-
FDA Removes Key Contraindications For Non-Surgical Treatment For Benign Prostatic Hyperplasia
-
FDA Approves Avelox, New Antibiotic For Bronchitis
-
FDA Approves Proceed Hemostatic Sealant For Sale In US
-
FDA Approves Zoloft For Post-traumatic Stress Disorder
-
FDA Approves Levulan Kerastick For Pre-Cancerous Skin Lesions
-
FDA Grants Conditional Premarket Application Approval For Glucowatch
-
FDA Approves Metadate ER, New Extended-Release Drug For ADHD
-
FDA Approves Nasonex For Use In Children As Young As Three
-
Tylenol, Specifically Designed For OA, Available In Canada
-
FDA Approves Keppra, Adjunctive Therapy For Epilepsy
-
FDA Approves Twice-Daily Dosing Of Viracept For HIV
-
FDA Approves Curosurf For Respiratory Distress In Premature Infants
-
Advair Approved In Canada For Treatment Of Asthma
-
FDA Approves Aggrenox For Patients With Previous Strokes
-
Vioxx Now Available In Canada For OA Symptoms
-
FDA Approves Remicade For Rheumatoid Arthritis Combination Treatment
-
FDA Clears 15-Minute Urine Test For Streptococcal Pneumonia
-
Canada approves Extraneal for Peritoneal Dialysis
-
European Union Approves Nasonex Nasal Spray For Kids With Allergies
-
Canada Approves Melacine Therapeutic Vaccine For Late-Stage Melanoma
-
FDA Clears Epogen For Treatment Of Anemia In Children On Dialysis
-
FDA Advisory Panel Recommends Prozac For Premenstrual Dysphoric Disorder
-
Canada Approves Relenza, An Inhaled Treatment For The Flu
-
Health Canada Approves Once-Daily Vioxx For Relief Of Osteoarthritis Symptoms
-
FDA Approves Once-Daily Dosing For Anti-HIV Drug Videx
-
FDA Approves Oral Tamiflu To Treat Common Flu
-
FDA Grants Orphan Drug Designation To Allovectin-7 For Melanoma Treatment
-
FDA Approves Ortho-Prefest For Menopause Symptoms
-
FDA Approves Aromasin For Advanced Breast Cancer
-
FDA Committee Recommends Avelox For Respiratory Tract Infections
-
Comtan Receives FDA Approval For Management Of Parkinson's Disease
-
FDA Approves New Dose For Prometrium For Endometrial Hyperplasia Prevention
-
FDA Extends Excedrin Migraine Indication To Full Migraine Syndrome
-
DIABETES CONFERENCE: GlucoNorm Approved In Canada For Type 2 Diabetes
-
FDA Approves Prozac For Seniors With Depression
-
FDA Approves Anti-Arrhythmic Drug, Tikosyn
-
FDA Approves Topamax For Combo Treatment Of Seizures
-
FDA Approves Rhinocort For Once-A-Day Relief Of Allergy Symptoms
-
FDA Approves Evista For Postmenopausal Osteoporosis
-
FDA Approves seven-day Estrogen Patch
-
Humalog Mix25 Available In Canada For Insulin-Dependent Diabetes
-
FDA Approves Synercid For Bloodstream And Skin Infections
-
Aggrastat(tm) Approved In Canada For Unstable Angina
-
FDA Approves Ellence, a New Breast Cancer Treatment
-
FDA Approves Rapamune To Prevent Kidney Transplant Rejection
-
Maxalt Approved In Canada For Migraine
-
NovoRapid Approved In Europe For Diabetes Treatment
-
FDA Approves Zerit And Videx As First Line HIV Therapy
-
Abelcet Approved In Belgium For Fungal Infections
-
Gluconorm Approved In Canada For Type 2 Diabetes
-
FDA Approves Aciphex For Reflux Disease And Duodenal Ulcers
-
Cipro Available In Canada For Swimmer's Ear
-
European Union Approves Remicade For Second-Line Treatment Of Crohn's Disease
-
FDA Approves Sonata For Treatment Of Insomnia
-
FDA Approves Cleocin For Bacterial Vaginosis
-
Zadaxin Approved In Brunei, Sri Lanka For Hepatitis B
-
FDA Approves Temodar For Refractory Anaplastic Astrocytoma
-
Zocor Approved To Raise HDL In People With High LDL
-
Integrilin Approved In Canada For Unstable Angina, Heart Attack
-
Paxene Launched In The Czech Republic For AIDS-Related Kaposi's Sarcoma
-
Antibiotic Synercid Approved In The U.K. For Life-Threatening Infections
-
Vitravene Approved In Europe For CMV In AIDS Patients
-
Zeffix Approved For Chronic Hepatitis B Treatment In The E.U.
-
FDA Approves Antagon For Women Undergoing Fertility Treatment
-
FDA Approves Plan B Emergency Contraceptive
-
Kytril Approved For The Prevention Of Radiation-Induced Nausea And Vomiting
-
Campto Approved In Europe For First-Line Advanced Colorectal Cancer Treatment
-
FDA Approves Relenza For The Treatment Of Influenza A and B
-
Rebetol Launched In The U.K. For Hepatitis C Treatment
-
Busulfex Injection Approved In Canada For Use In Transplant Patients
-
FDA Approves Topamax For Pediatric Epilepsy
-
Fraxiparine Forte Now Available In Canada For Dangerous Blood Clots
-
Fast-Dissolving Version Of Zomig Approved In Sweden For Migraine
-
FDA Approves Velosulin BR For Diabetes Treatment
-
Cenestin Now Available In The U.S. For Menopause Symptoms
-
Photofrin Receives Approval For Lung Cancer In Canada
-
Actos Approved By FDA For Type II Diabetes
-
Twice-Daily Amoxil Available In U.S.
-
FDA Grants Orphan Drug Designation To SomatoKine For Severe Burns
-
Vivelle-Dot Now Available In The U.S. For ERT
-
EU Approves Integrilin For The Prevention Of Early Myocardial Infarction
-
FDA Approves Reformulated Norvir Capsule For Combination HIV Treatment
-
Doxil Approved For Refractory Ovarian Cancer
-
Ziagen Approved In Canada For HIV Treatment
-
Antizol Injection Approved For Ethylene Glycol Poisoning In UK
-
FDA Approves Fosamax For Glucocorticoid-Induced Osteoporosis
-
Newest HIV Protease Inhibitor, Agenerase, Now Available in Oral Solution
-
Rebetol Launched In Germany For Use In Combination Therapy For Chronic Hepatitis C
-
FDA, Parke-Davis Urge Limits On Rezulin Use
-
Retavase Available In Canada For Emergency Heart Attack Treatment
-
Ferrlecit Available In The U.S. For Anemia In Hemodialysis Patients
-
Xenical Approved In Canada For Obesity
-
Lamictal Approved In Canada For Rare Childhood Epilepsy
-
Muse Now Available In Germany For Erectile Dysfunction
-
Vioxx Now Available In U.S. For Menstrual Pain, Osteoarthritis
-
Vioxx Approved In The U.K. For Osteoarthritis
-
Humate-P Approved For Treatment Of Bleeding Episodes In Von Willebrand Disease
-
Sonata Launched In Germany For Insomnia
-
Cosopt Approved In Canada For Glaucoma Treatment
-
Lamisil Spray Available In Canada To Treat Fungal Skin Conditions
-
Alertec Available In Canada For Narcolepsy
-
Once-Daily Anti-HIV Drug Sustiva Approved In Europe
-
FDA Approves Enbrel For Juvenile Rheumatoid Arthritis
-
Zadaxin Approved In Malaysia For Hepatitis B
-
FDA Approves Fragmin For Unstable Angina And Non-Q-Wave MI
-
Modafinil Available In Austria For Narcolepsy
-
FDA Approves New Dose Of Baycol, Adds New Indications
-
FDA Approves Avandia For Type II Diabetes
-
Zeffix Launched In South Korea For Treatment Of Chronic Hepatitis B
-
FDA Approves Vioxx For Osteoarthritis, Acute Pain In Adults And Menstrual Pain
-
Sonata Launched In Denmark And Sweden For Insomnia
-
Prozac Tablet To Be Available In The U.S. June 1, 1999
-
Avalide Available In U.S. For High Blood Pressure Treatment
-
FDA Approves Paxil In The U.S. For Social Anxiety Disorder
-
Tobi Approved In Canada For Cystic Fibrosis
-
Copaxone Approved In Switzerland For Relapse-Remitting Multiple Sclerosis
-
Lamisil Now Available OTC In The U.S. For Athlete's Foot Treatment
-
Vivelle-Dot Available In The U.S. For Menopause Symptoms
-
Rebetol Approved In EU For Chronic Hepatitis C Treatment
-
Paxil Approved In Canada For Social Anxiety Disorder
-
Synvisc Launched In Mexico, Peru For Osteoarthritis Pain
-
Rebetron Approved In Canada For All Hepatitis C Patients
-
Atridox Approved In Europe For Periodontal Disease
-
New Arthritis Treatment, Celebrex, Available In Canada
-
Weight-Loss Drug Xenical Approved In U.S. For Treatment Of Obesity
-
New Twice-Daily Pediatric Amoxil Approved By FDA
-
ReFacto Approved In Europe For Hemophilia A Treatment
-
FDA Approves Agenerase For HIV Treatment
-
Celebrex Approved In Canada For Arthritis
-
NovoSeven Available In U.S. For Hemophilia
-
Regranex Approved In EU For Diabetic Foot Ulcers
-
Celebrex Approved In Switzerland For Arthritis
-
NSAID Patch, Diclofenac, Launched In Argentina
-
FDA Approves Sporanox For Fungal Infections
-
FDA Approves Fragmin For Prevention Of Deep Vein Thrombosis
-
Actiq Now Available In The U.S. For Breakthrough Cancer Pain
-
Synvisc Approved In South Africa For Osteoarthritis Pain
-
FDA Approves NovoSeven For Treatment Of Hemophilia
-
Zadaxin Approved In Pakistan For Hepatitis B, Hepatitis C And Cancer
-
Relenza Approved In Australia For Influenza Treatment
-
FDA Approves Xopenex For Bronchospasm Treatment
-
FDA Approves Cenestin For Menopause Symptoms
-
FDA Approves Nabi-HB For Hepatitis B Exposure
-
FDA Approves Epivir For Use In HIV Patients Three-Months Old And Up
-
Viagra Available In Canada March 25, 1999
-
Growth Hormone Norditropin Approved In Denmark
-
Cloderm Cream Now Available In The U.S.
-
Sustiva, First Once-Daily Anti-HIV Drug, Approved In Canada
-
Verelan PM Launched In The U.S. For Essential Hypertension
-
FDA Approves Lidoderm For Postherpetic Neuralgia Pain
-
Hylaform Approved In Australia For Correction Of Facial Wrinkles, Depressed Scars
-
Sonata Approved In Europe For Insomnia
-
Zadaxin Approved In Vietnam For Hepatitis B, Singapore For Hepatitis C
-
Paxene Approved In Czech Republic For AIDS-Related Kaposi's Sarcoma
-
FDA Approves Mevacor In People With Average Cholesterol Levels
-
Xalatan Approved In Japan For Glaucoma And Ocular Hypertension
-
Effexor XR Approved In The U.S. For Anxiety
-
FDA Approves Lamisil For Switch To OTC In Athlete's Foot Treatment
-
Non-prescription Drugs To Get New, Easy-To-Understand Labels In The U.S.
-
Rebetron Approved In Canada For Hepatitis C
-
FDA Grants Approval To Amaryl For Combination Use With Metformin
-
Viagra Approved In Canada For Erectile Dysfunction
-
FDA Approves New Lescol Indication To Reduce Triglycerides And Apo B
-
FDA Approves Low Dose Climara Patch For Osteoporosis Prevention
-
Brexidol Approved In Canada For Acute Pain
-
Alertec Approved In Canada For The Treatment Of Narcolepsy
-
Recombinant Glucagon Available In U.S. For Severe Hypoglycemia
-
Regranex Approved In Canada For Diabetic Ulcer Treatment
-
Busulfex Injection Available In The U.S. For Chronic Myelogenous Leukemia
-
Celebrex Now Available In The U.S. For Arthritis Treatment
-
Reductil Approved In Switzerland And South Africa For Obesity Management
-
Micardis Available In U.S. For Hypertension
-
New Warnings Placed On Rebetron Hepatitis Therapy
-
Serevent Approved In Canada For COPD
-
Activase Approved In Canada For Acute Management Of Stroke
-
Zydone Now Available In U.S. For Pain Management
-
Lipitor Approved In Canada For Three New Indications
-
Estrogel Available In Canada For ERT
-
Tobi Approved In Canada And Argentina For CF
-
Provigil Now Available In The U.S. For Narcolepsy
-
NiaStase Approved In Canada As Clot Forming Aid In Treatment Of Hemophilia
-
Celebrex Approved in Mexico For Treatment Of Arthritis
-
Regranex Approved In Canada For Diabetic Foot Ulcer Treatment
-
Celexa Approved In Canada For Treatment Of Depression
-
FDA Approves Orally-Disintegrating Formulation Of Zofran
-
FDA Approves Ontak For Cutaneous T-Cell Lymphoma
-
FDA Approves Busulfex Injection As Part Of Myelogenous Leukemia Treatment
-
FDA Approves Panretin Gel For AIDS-Related Kaposi's Sarcoma
-
FDA Approves Pediatric Use Of Maxipime For Injection
-
Provigil Available In The Republic Of Ireland For Narcolepsy
-
Ditropan XL Now Available In U.S. For Overactive Bladder
-
Parke-Davis Revises Cerebryx Labels In The U.S. Due To Overdose Complications
-
Pfizer Revises Trovan Prescribing Information In The U.S.
-
EU Approves Temodal For Recurrent Glioblastoma Multiforme
-
Viagra Approved In Japan For Erectile Dysfunction
-
COX-2 Inhibitor, Celebra, Approved In Brazil For Arthritis Treatment
-
FDA Grants Priority Review To Vioxx For Osteoarthritis And Pain
-
Nicorette Mint Now Available As OTC Drug In U.S.
-
Trovan Antibiotic Now Available In Canada
-
Reductil Approved In Germany For Management Of Obesity
-
FDA Approves Pleatal For Intermittent Claudication
-
Abelcet Approved In The Netherlands For Severe Systemic Fungal Infections
-
FDA Grants Priority Review To Vioxx For Osteoarthritis And Pain
-
FDA Approves World's Smallest Transdermal Estrogen Delivery System
-
Lamivudine Approved For Hepatitis B In China
-
Proleukin Approved In Canada For Metastatic Melanoma
-
Photofrin Approved In UK For Palliation Of Esophageal, Late-Stage Lung Cancer
-
FDA Approves Thymoglobulin To Prevent Acute Kidney Rejection
-
Zadaxin Approved For Hepatitis B And C In Venezuela
-
FDA Approves OTC ProStep Nicotine Patch
-
FDA Approves Celebrex For Osteoarthritis And Rheumatoid Arthritis
-
FDA Approves Prometrium For Use With Hormone Replacement Therapy
-
New Prescription Treatment Available For Uncomplicated Urinary Tract Infection
-
FDA Clears Agrylin For A Broader Patient Population
-
FDA Approves Ziagen For Inclusion In AIDS/HIV Combination Drug Therapy
-
FDA Approves Conversion Of Lamictal To Single-Drug Treatment For Epilepsy
-
Ditropan XL Approved For Treatment Of Overactive Bladder
-
Zadaxin Approved In Mexico, Cambodia As Immune System Enhancer
-
CytoGam Approved For Prophylaxis Against CMV Disease
-
FDA Approves Oral Epivir-HBV For Chronic Hepatitis B
-
Combivir Approved In Canada For HIV Treatment
-
Fosamax Approved In Canada For Steroid-Induced Osteoporosis
-
Hycamtin Approved For Use As Second-Line Treatment Of Small Cell Lung Cancer
-
Detrol Approved In Canada For Overactive Bladder
-
Serostim Approved In Canada For Treatment Of HIV Wasting
-
FDA Approves Thyrogen For Thyroid Cancer
-
Heptovir Approved In Canada For Chronic Hepatitis B
-
FDA Approves Verelan PM For Essential Hypertension
-
FDA Approves Sandostatin For Symptoms Of Pituitary, Intestinal And Carcinoid Tumous
-
Viagra Labels Tri-blue To Include New Warnings
-
Evista Approved In Canada For Postmenopausal Osteoporosis
-
Vantin Receives Approval For Five-Day Treatment In Acute Otitis Media
-
NiQuitin CQ Now Available In Europe
-
FDA Approves Pediatric Viramune For HIV Treatment
-
FDA Approves Activelle For Hormone Replacement Therapy
-
First Capsule For Adult Periodontitis, Periostat, Available in U.S.
-
Glaxo's Raxar Available In New Dosage Forms For Respiratory Infections
-
Diane-35 Available In Canada To Treat Severe Acne In Women
-
Atridox Therapy Now Available In U.S. For Periodontal Disease
-
Vitravene Available In U.S. For CMV Retinitis In AIDS Patients
-
Precose Receives FDA Clearance For Combination Therapy In Type 2 Diabetes
-
Abelcet Approved For Systemic Fungal Infections In Singapore
-
FDA Approves Actiq For Breakthrough Cancer Pain
-
Asmabec Clickhaler Approved In UK For Asthma Attack Prevention
-
FDA Approves Enbrel For Rheumatoid Arthritis
-
FDA Committee Recommends Ziagen For Combination Treatment Of HIV/AIDS
-
FDA Approves Renagel Capsules For Patients With End Stage Renal Disease
-
FDA Approves Nolvadex For Breast Cancer Prevention In High-Risk Women
-
Camptosar Approved For Colorectal Cancer
-
Professional Labelling Of Aspirin To Highlight Cardiovascular Benefits
-
Atacand Available In U.S. For Hypertension
-
FDA Approves Versed Syrup For Pediatric Pre-Operative Sedation
-
FDA Approves Once-A-Day Dosing Of Pulmicort Tubuhaler For Asthma
-
Synvisc Approved In Argentina, Brazil For Osteoarthritis
-
Remicade Now Available In U.S. For Crohn's Disease
-
Transderm-V Reintroduced In Canada
-
Atrovent Now Available for Children Six Years And Up
-
Omnicef, A Broad Spectrum Cephalosporin Antibiotic, Available In The U.S.
-
Thalomid Launched In U.S. For Leprosy Condition
-
CombiPatch Now Available In U.S. For Menopause Symptoms
-
Pramdin Approved In Italy For Nausea And Vomiting
-
FDA Approves Herceptin For Breast Cancer
-
FDA Approves Asthma Drug Serevent Diskus For Use In Children Four And Up
-
Sustiva Approved In U.S. As Part Of HIV Combination Therapy
-
Anti-HIV Drug Viramune Approved In Canada
-
Caelyx Approved In Canada For Kaposi's Sarcoma
-
Viagra Approved In Europe For Erectile Dysfunction
-
PerioChip Now Available In The U.S. For Periodontitis Treatment
-
Retavase Approved For Heart Attack Treatment In Canada
-
FDA Approves Arava For Treatment Of Adult Rheumatoid Arthritis
-
Abelcet Approved In Australia For Fungal Infection
-
FDA Approves Atridox Periodontal Disease Treatment
-
FDA Advisory Committee Recommends Valstar For Bladder Cancer
-
Preven Emergency Contraceptive Kit Approved by the FDA
-
FDA Grants Atrovent Nasal Spray Pediatric Indication For Rhinorrhea
-
FDA Approves Lamictal For A Difficult-To-Treat Childhood Epilepsy
-
FDA Approves Gemzar For First-Line Treatment Of Non-Small Cell Lung Cancer
-
FDA Approves Vitravene For CMV Retinitis
-
FDA Approves Intron A For Pediatric Use In Chronic Hepatitis B
-
FDA Approves Remicade For Crohn's Disease
-
Lamivudine Approved In The Philippines For Hepatitis B
-
AmBisome Now Approved In UK For Presumed Fungal Infections
-
NovoNorm Approved By EU For Type II Diabetes
-
Nicotine-Free Zyban Approved To Help Canadians Quit Smoking
-
Hep B Vaccine Approved For Use In Hep C Patients
-
Agouron's Viracept Receives Marketing Approval In Canada
-
FDA Approves CombiPatch Hormone Replacement Therapy
-
FDA Panel Recommends Arava For Adult Rheumatoid Arthritis
-
FDA Approves Certiva Vaccine For Diphtheria, Tetanus And Pertussis
-
Agrylin Approved In Israel For Essential Thrombocythemia
-
Famvir Approved In Canada To Prevent Genital Herpes
-
FDA Approves Zoladex For Early Stage Prostate Cancer
-
Mircette, Low-Dose Oral Contraceptive, Available In U.S.
-
FDA Panel Recommends Vitravene For CMV Retinitis
-
FDA Approves Celexa For The Treatment of Depression
-
FDA Clears Thalidomide For Leprosy
-
Virazole Cream Approved In Russian Federation For Treatment Of Herpes
-
FDA Approves DRYalysate For Hemodialysis
-
Clopidogrel Receives European Marketing Approval For Atherosclerotic Events
-
Twice-Daily Amoxil Receives FDA Approval
-
FDA Approves Levlite Low-Dose Oral Contraceptive
-
Invicorp Approved In Denmark For Erectile Dysfunction
-
FDA Approves New Dosage Range For Cholesterol-Lowering Drug Zocor
-
New Labelling Introduced For Tylenol and Motrin IB
-
FDA Clears Palladium-103 Brachytherapy For Prostate Cancer
-
TheraTech's Androderm Launched In Germany
-
Propecia Now Available In Canada For Male Pattern Hair Loss
-
Triple Therapy Including Prilosec Approved For H. Pylori Treatment
-
FDA Approves Maxalt To Relieve Migraine Pain And Symptoms
-
FDA Approves GlucaGen For Severe Hypoglycaemia, Radiological Diagnostic Aid
-
Quadramet Receives Canadian Approval For Bone Pain
-
FDA Approves Synagis For Prevention Of RSV In Infants
-
FDA Approves Famvir For Treatment Of Herpes In People With HIV
-
FDA Approves Sulfamylon For Prevention Of Burn Wound Infection
-
New One-Dose Monistat Available In The U.S.
-
Nicoderm Patch Available In Canada Without Prescription
-
FDA Clears New Labelling For Pravachol
-
Atacand Receives FDA Approval For Hypertension
-
FDA Approves Rebetron Combination Therapy For Chronic Hepatitis C
-
Zyrtec Approved For Allergic Rhinitis In Children Two To Five Years Old
-
FDA Committee Recommends Hycamtin For Small Cell Lung Cancer
-
TriCor, Micronized Fenofibrate, Now Available In U.S. For High Triglycerides
-
FDA Panel Recommends Broader Use Of Taxotere For Breast Cancer
-
Vasomax Approved In Mexico For Erectile Dysfunction
-
FDA Advisory Committee Recommends Infliximab For Treatment Of Crohn's Disease
-
FDA Approves Apligraf For Venous Leg Ulcers
-
Habitrol Nicotine Patch To Be Available Over-The-Counter In Canada
-
Muse Approved In South Africa For Erectile Dysfunction
-
Simulect Approved To Prevent Acute Rejection Of Kidney Transplants
-
Solarase Approved In Canada For Precancerous Skin Lesions
-
FDA Approves Integrilin For Both Acute Coronary Syndrome And Angioplasty
-
FDA Approves Oral Progesterone Prometrium
-
FDA Approves Simulect For Acute Rejection Prevention In Renal Transplants
-
FDA To Rush Review Of SP-303/Provir As Anti-Diarrheal For AIDS Patients
-
Cystrin CR Launched In Finland For Urinary Incontinence
-
Colazide Approved In Six European Countries
-
Eloxatin Receives Expanded Indication For Metastatic Colorectal Cancer
-
Solarase Approved In Europe For Treatment Of Sunspots
-
Carbatrol Launched In The U.S. For Epilepsy
-
AmBisome Approved In New Zealand, DaunoXome Approved In Australia
-
Activa Therapy Released In Europe For Relief Of Parkinson's Symptoms
-
Geref Products Launched For Diagnosis and Treatment of Growth Problems
-
New Antidepressant, Effexor XR, Released In Canada
-
FDA Approves Zemplar For Hyperparathyroidism In Chronic Renal Failure
-
Oxandrin Receives Marketing Clearance In South Korea and Azerbaijan
-
Oral Contraceptive, Mircette, Receives FDA Approval
-
Flovent Rotadisk Now Available For Asthmatic Children Four Years And Older
-
Chronovera Available In Canada For High Blood Pressure
-
Regranex Gel For Diabetic Foot Ulcers Now Available In U.S.
-
FDA Clears TAP's Prevacid For GERD
-
FDA Panel Recommends Merck's Aggrastat For Unstable Angina
-
Gliadel Wafer Receives Marketing Approval In Argentina
-
FDA Approves Cosopt Combination Eye Drops
-
FDA Approves New Drug For Paget's Disease
-
FDA Clears Zocor To Reduce Risk of First Stroke Or Transient Ischemic Attack
-
ACC MEETING: Study Shows Pravachol Reduces Risk Of Stroke
-
Quadramet Is Effective In Relieving Pain Of Spreading Cancer
-
FDA Grants New Indications For Cholesterol Drug Pravachol
-
FDA Approves Viagra For Impotence
-
FDA Approves DDAVP Tablets For Bed-Wetting
-
FDA Approves Detrol For Urinary Problems Caused By Overactive Bladder
-
FDA Approves New Proscar Indication To Reduce Need For Prostate Surgery
-
Amerge Tablets Now Available In U.S. For Migraine Attacks
-
Zadaxin Approved In Kuwait For Hepatitis B
-
FDA Panel Wants Breast Cancer Drug Xeloda Approved Quickly
-
FDA Panel Recommends Gemzar Alone Or With Cisplatin For Lung Cancer
-
New AIDS Drug Ziagen Made Available Through Expanded Access Program
-
Detrusitol Launched In The UK And Germany For Unstable Bladder
-
FDA Approves Ophthalmic Products, Lotemax And Alrex
-
Refludan Approved For Heparin-Induced Thrombocytopenia
-
Viracept Receives Japanese Approval For HIV
-
Estalis Patch Cleared In Sweden For Menopause Symptoms
-
FDA Grants Traditional Approval To Crixivan For HIV
-
Mirapexin Approved In Europe For Parkinson's Disease
-
Provigil Launched In U.K. For Narcolepsy
-
Expanded Indications Approved For Dynabac Antibiotic
-
Three-Day Treatment For Bacterial Vaginosis Gets FDA Approval
-
Wafer Cleared In Brazil For Malignant Brain Tumours
-
Ultra Low Dose Statin, Baycol, Launched In Canada
-
Anzemet Now Available For Oncology And Surgery Patients
-
Singulair, A New Option In Asthma Treatment, Approved By FDA
-
FDA Panel Recommends Synercid
-
Topical Solution Addresses Parents' Concerns With Ear Infections
-
First Corticosteroid Dry Powder Inhaler For Asthma Now Available In U.S.
-
New Psoriasis Treatment Clears Lesions, Eases Pain
-
Rebif Approved And Launched In Canada
-
Baycol, A Cholesterol-Lowering Treatment, Launched In U.S.
-
Salagen Tablets Indication Extended To Dry Mouth In Sjogren's Syndrome
-
Tricor Receives FDA Approval For Very High Triglycerides
-
FDA Approves CellCept Combination For Heart Transplantation
-
FDA Approves Amerge For Migraine Treatment
-
CytoGam Cleared In Mexico And Poland For CMV Disease
-
New Hismanal Labelling Warns Of Drug Interaction Complications
-
FDA Clears New Dose For Arthritis Drug Lodine
-
Organ Rejection Drug Also Shows Promise For The Treatment Of Kidney Disease
-
Migranal Nasal Spray Available In U.S. For Migraine Headaches
-
FDA Approves Pediatric Use For Viroptic
-
FDA Clears Repose - A Treatment For Obstructive Sleep Apnea And Snoring
-
FDA Approves Avita Gel For The Treatment Of Acne
-
SmartMist System For Delivery Of Asthma Medication Now Available In US
-
UK Approves Asacard Cardiovascular Aspirin
-
FDA Clears Parkinson's Drug Tasmar
-
VasoCare Therapy Approved In Europe For Blocked Peripheral Arteries
-
Alesse Approved For Sale In Canada
-
FDA Approves Permethrin Cream 5% For Scabies
-
Raloxifene Shows Promise As Ideal Hormone Therapy For Some Women
-
New Dose Of Leading Hormone Replacement Therapy Approved In U.S.
-
Prilosec Available In New 40mg Dosage Strength
-
Abelcet Receives First-Line Approval In Hong Kong
-
Noritate Available For Treatment Of Rosacea
-
FDA Clears Cryosurgical
Treatment For Verruca Plana
-
Nicorette Gum Recommended As OTC Products In Canada
-
Propecia Now Available In U.S.
-
PhotofrinĘ Approved For Treatment Of Lung Cancer
-
Daclizumab Prevents Rejection Episodes In Kidney Transplant Patients
-
Clexane/Lovenox Receives 11 Approvals As Treatment for Unstable Angina
-
FDA Clears Excedrin Migraine For Migraine Headache Pain
-
FDA Approves Treatment For Malignant Pleural Effusion
-
More Approved Drugs/Indications
|
